Astronomers track object that may have originated outside the solar system
Scientists have discovered what might be only the third known interstellar object to pass through our solar system, the European Space Agency said Wednesday.
The harmless object is currently near Jupiter hundreds of millions of miles (kilometers) away and moving toward Mars, but it should get no closer to the sun than that, according to scientists.
It's too soon to know whether the object, designated for now as A11pl3Z, is a rocky asteroid or a icy comet, or how big and what shape it is. More observations are needed to confirm its origins. NASA said it is monitoring the situation.
Astrophysicist Josep Trigo-Rodriguez of the Institute of Space Sciences near Barcelona, Spain, believes it is an interstellar object based on its odd path and extreme speed cutting through the solar system. He estimates its size at roughly 25 miles (40 kilometers) across.
The first confirmed interstellar visitor was in 2017. It was dubbed Oumuamua, Hawaiian for scout, in honor of the observatory in Hawaii that discovered it. Classified at first as an asteroid, the elongated Oumuamua has since showed signs of being a comet.
The second object confirmed to have strayed from another star system into our own is 21/Borisov, discovered in 2019 and believed to be a comet.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
21 minutes ago
- Medscape
Sunvozertinib Wins Approval for EGFR-Mutated NSCLC
The FDA has granted accelerated approval to sunvozertinib (Zegfrovy, Dizal Pharmaceutical) for locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor ( EGFR) exon 20 insertion mutations that's progressed on or after platinum-based chemotherapy. The agency also approved Oncomine Dx Express Test (Life Technologies Corporation) as a companion diagnostic to detect the mutations. The oral EGFR inhibitor is the first small molecule approved in the US for the indication; it was previously approved in China. The intravenous bispecific antibody amivantamab-vmjw (Rybrevant, Johnson & Johnson) also carries a second-line indication for EGFR exon 20 insertion mutated advanced/metastatic NSCLC, as well as a first-line indication with carboplatin and pemetrexed. Dizal is going for a first-line indication, too. The company recently announced completion of enrolment in a phase 3 trial pitting sunvozertinib against platinum-based chemotherapy for the upfront treatment of EGFR exon 20 insertion mutated NSCLC. The new second-line approval was based on WU-KONG1B, a multinational dose finding trial. All subjects had previous platinum-based chemotherapy and 43.4% had also received immunotherapy; 13.3% had been on amivantamab. Among 85 patients on 200 mg sunvozertinib daily, the overall response rate was 46% and the duration of response was 11.1 months. Labelling warns of the possibility of interstitial lung disease/pneumonitis, gastrointestinal adverse reactions, dermatologic issues, ocular toxicity, and embryo-fetal toxicity. Diarrhea, skin rash, and creatine phosphokinase increase were the most common drug-related treatment emergent adverse events in the trial, with most events being grade 1 or 2. The recommended dose is 200 mg orally once daily with food until disease progression or unacceptable toxicity. M. Alexander Otto is a physician assistant with a master's degree in medical science and a journalism degree from Newhouse. He is an award-winning medical journalist who worked for several major news outlets before joining Medscape. Alex is also an MIT Knight Science Journalism fellow. Email: aotto@
CNET
26 minutes ago
- CNET
See the First Breathtaking Celestial Images From the Vera C. Rubin Observatory
A sneak preview of the first batch of deep space imagery from the new Vera C. Rubin Observatory in Chile made its way to news sites and social media last week, followed by a livestream event. "(The Rubin Observatory is) going to build the greatest time-lapse movie of the cosmos ever made," the observatory said in a post. The observatory is named for the American scientist widely credited for finding some of the first evidence of dark matter, with the project being funded by the National Science Foundation and the US Department of Energy's Office of Science. The scientists and officials from the NSF and DOE participated in a news conference and Q&A about the findings last week. You can watch the stream below. Millions of galaxies, big images Though the livestream was plagued by a few technical issues, it still offered some context on what data is being captured at the Rubin Observatory and why. "Starting today, our ability to understand dark matter, dark energy and planetary defense will grow even faster than ever before," said Brian Stone, the NSF's chief of staff. The observatory's 3,200-megapixel camera is used for a full-sky scan that happens every three to four days. Stunning images that the observatory shares are only a fraction of what is being captured, in some cases showing only 2 percent of the full view, which would require 400 HDTVs to show. One image can capture 10 million galaxies. Closer to Earth, astronomers have discovered 1 million asteroids in our solar system and expect to discover 5 million more in the next few years.
Associated Press
26 minutes ago
- Associated Press
NASA identifies newly discovered object as an interstellar comet that will keep a safe distance
CAPE CANAVERAL, Fla. (AP) — NASA has discovered an interstellar comet that's wandered into our backyard. The space agency spotted the quick-moving object with the sky-surveying Atlas telescope in Chile earlier this week, and confirmed it was a comet from another star system. It's officially the third known interstellar object to pass through our solar system and poses no threat to Earth. The newest visitor is 416 million miles (670 million kilometers) from the sun, out near Jupiter. NASA said the comet will make its closest approach to the sun in October, scooting between the orbits of Mars and Earth — but closer to the red planet than us at a safe 150 million miles (240 million kilometers) away. Astronomers around the world are monitoring the comet — an icy snowball officially designated 3I/Atlas — to determine its size and shape. It should be visible by telescopes through September, before it gets too close to the sun, and reappear in December on the other side of the sun. The first interstellar visitor observed from Earth was Oumuamua, Hawaiian for scout, in honor of the observatory in Hawaii that discovered it in 2017. Classified at first as an asteroid, the elongated Oumuamua has since showed signs of being a comet. The second object confirmed to have strayed from another star system into our own —— 21/Borisov — was discovered in 2019 by a Crimean amateur astronomer with that name. It, too, is believed to be a comet. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
